MAO (monoamine oxidase) inhibitors are a category of antidepressants that, when applied in combination with copyright amphetamines like three-MMC or copyright, may possibly cause a possibly lethal affliction often known as “serotonin syndrome.”It is a popular example of a contemporary designer drug especially chosen to imitate and/or change the